TBC1D3P1-DHX40P1

Across TCGA pan-cancer cohorts, TBC1D3P1-DHX40P1 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated TBC1D3P1-DHX40P1 data layer compared with 19 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher TBC1D3P1-DHX40P1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TBC1D3P1-DHX40P1 expression acts as an unfavorable survival marker.

SKCM, COAD, and LUAD are the cancer types where TBC1D3P1-DHX40P1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Median	All	0.446	0.787	<.001	30	view →
COAD	OS	Median	All	0.103	0.801	<.001	24	view →
LUAD	OS	Median	All	0.258	0.787	.018	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

TBC1D3P1-DHX40P1–SKCM (OS)

Open the SKCM breakdown →